NCT00933985 2014-05-01Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or LeukemiaNational Cancer Institute (NCI)Phase 1 Terminated22 enrolled
NCT00003166 2013-01-11Bryostatin and Vincristine in B-Cell MalignanciesNational Cancer Institute (NCI)Phase 1 Completed18 enrolled
NCT00080925 2012-03-08T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic MalignanciesNational Institutes of Health Clinical Center (CC)Phase 1 Completed20 enrolled
NCT00012207 2010-08-24Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaFred Hutchinson Cancer CenterPhase 1 Completed12 enrolled